Delay in AS dx appeared to be BMI-dependent in female pts and both genders n PsA dx. In contrast to AS, SEC treatment response of early- and late-diagnosed PsA pts did not differ. Abs 1497 #ACR22 @RheumNow https://t.co/LBo3XapAT4 https://t.co/uAcfeiED4F

• How Does Time to Diagnosis and Gender Affect Treatment Outcomes in Patients wit…

Lower socioeconomic status (cluster 1) patients: ● older age at the diagnosis (37.9 vs. 32.6) ● longer diagnosis delay (7.8 vs. 6.8 years) ● higher BMI (27.6 vs. 25.9) ● greater structural damage vs cluster 2 Lopez-Medina C Abs0376 https://t.co/wXOksFGDKl #ACR22 @RheumNow https://t.co/1YVRA6r1sw

• The Socioeconomic Profile of Patients with Radiographic Axial Spondyloarthritis…

13S150. Draft ACR/EULAR APLS Classif Criteria #ACR22 Novel Aspects Macrovascular Domains - Venous and Arterial by Low and High VTE, CVD risk profiles Microvasc - Suspected/Established @RheumNow https://t.co/M8NWRSyH4p

#abs1235 #acr22 @rheumnow articular fibroblast activation in PSO assessed by 68Ga-FAPI-04 PET-CT assoctd w/⬆️ risk of developing PsA. 10 pts assessed: 6/7 pts (85.7%)w/ 68Ga-FAPI-04 uptake at synovio-entheseal sites progressed to PsA. median PsA-free time 207 (160-240)days https://t.co/Y6EHPaDwfh

PsA pts starting 1st DMARD tx, both early & late initiators experienced dz activity and PRO improvements up to 6 months post-initiation. Better response, including MDA, achieved in pts initiating DMARD tx w/in 1 yr of dx. Abs 1493 #ACRbest #ACR22 @RheumNow https://t.co/a94sZRQ3VF https://t.co/OSUEoChtFf

• Impact of Delay of Treatment with Disease Modifying Antirheumatic Drugs (DMARDs…

🌟PSA vs RA 🌟 -UK cohort PSA associated with: 👉⬆️ duration symptoms prior 2 referral 👉⬆️ interval between GP presentation and DX 👉⬇️DMARD commencement 👉⬇️ improvement in Dx activity @ 3/12 # We need to do better #ACR22 Abst#1613 @RheumNow

Patients with PsA and AS who used opioids had higher healthcare utilization and higher costs. Also ➣ more comorbidities ➣ higher prevalence of smoking ➣ worse disease activity ➣ higher use of anti-rheumatic drugs Ogdie A Abs0402 https://t.co/3E4qAuqgpI #ACR22 @RheumNow https://t.co/AaKxiQXMwx

• Opioid Use and Healthcare Utilization in Adults with PsA and AS - ACR Meeting A…

Guan et al. Accuracy of financial disclosures in rheumatology journals. 76% papers >=1 inaccuracy. 78% authors >= undisclosed/underreported COI. Worse in clinical trials 85% @RheumNow #ACR22 Abstr#1267 https://t.co/dmqp3sj11f https://t.co/UXQgUCcGWb

• Accuracy of Financial Disclosures in American-Based Rheumatology Journals - ACR…

What are we treating PMR with? RISE registry, 2016-20 (n=26,102 in US) - Such a small proportion ever see non-steroid therapies - Big chunk remain on steroids or lost to follow-up Surely we can improve PMR care! ABST1546 @SattuiSEMD @RADoctor #ACR22 @RheumNow https://t.co/Ocuw5WxKu2

Don't stop HCQ even after ESRD occurs in #LupusNephritis! 1578 pts w/ESRD on HCQ only, GCs only or HCQ+GCs (n=509). HCQ groups had lower cardiac complications & infx compared to steroid only group. No diff. in thrombosis & all-cause mortality. #ACR22 @rheumnow #ACRbest abst#0539

Lee et al. 55% of requested cryoglobulin tests not successfully completed. @RheumNow #ACR22 Abstr#1281 https://t.co/QLCEFueeHi https://t.co/toEUukyXQf

• Less Than Half of Cryoglobulin Tests Ordered at a Tertiary Hospital Network Are…

Higher NSAID intake is assoc'd w/ lower radiographic spinal progression, particularly in r-axSpA patients. COX2i might have stronger inhibitory effect on radiographic progression compared to NS-NSAIDs. @ProftDr @RheumNow Abs 1492 #ACR22 https://t.co/l51wMqm5fB https://t.co/UaBCRRSJEE

• Treatment with Non-steroidal Anti-inflammatory Drugs Is Associated with Retarda…

Subclinical GCA in PMR 🌟US findings of GCA in 22% PMR pts w/o signs or symptoms of GCA 🔥Different US pattern vs classical GCA Subclinical GCA: 👉predilection extra-cranial arteries 👉⬆️ IMT of large vessels #ACR22 @RheumNow Abst#1619 https://t.co/HV9dsTBfg8

Nurses’ Health Study - 34 yr f/u data #gout - women with gout have ⬆️ risk of all-cause mortality, - primarily driven by ⬆️ risk of CVD deaths. #ACR22 @rheumnow abst#1757 https://t.co/K2ykelHAlL

13S150. Draft ACR/EULAR APLS Classif Criteria ⭐️Reminder: Classification = high specificity, not Diagnostic Crit! ⭐️Previously Sapporo: clinical (vasc/preg) + immunologic -- Lack of risk stratification, unclear definition of aPL+, no valvulopathy, outdated pregnancy @Rheumnow